Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma

ClinicalTrials.gov ID: NCT00057564

Public ClinicalTrials.gov record NCT00057564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 9:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy of combination oral thalidomide plus oral dexamethasone treatment to that of oral dexamethasone-alone treatments as induction (first-line) therapy for subjects with active multiple myeloma

Study identification

NCT ID
NCT00057564
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene Corporation
Industry
Enrollment
470 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2003 (Type not available)
Primary completion
Apr 2006 (Actual)
Completion
Aug 2013 (Actual)
Last update posted
Sep 11, 2015

2003 – 2013

United States locations

U.S. sites
26
U.S. states
18
U.S. cities
23
Facility City State ZIP Site status
Clinical Research Consultants, Inc. Hoover Alabama 35216 —
Arizona Clinical Research Center Tucson Arizona 85712 —
UCLA School of Medicine Los Angeles California 90095 —
James Berenson West Hollywood California 90069 —
Mayo Clinic Jacksonville Florida 32224 —
Melbourne Internal Medicine Associates Oncology Melbourne Florida 32901-3182 —
Jackson Memorial Hospital and Clinics Miami Florida 33136 —
University of Miami Miller School/Jackson Memorial Hospital Miami Florida 33136 —
University of Miami Miami Florida 33136 —
Oncology Hematology Group of South Florida Miami Florida 33176 —
Medical College of Georgia Augusta Georgia 30912-3125 —
Southern Illinois Hematology /Oncology Centralia Illinois 62801 —
Rush Cancer Institute Section of Hematology Chicago Illinois 60612-3824 —
University of Iowa Hospital of Clinic Iowa City Iowa 52242 —
Ocshner Clinic Foundation New Orleans Louisiana 70121 —
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0922 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
Hackensack University Hospital Hackensack New Jersey 07601 —
SUNY Upstate Medical University Syracuse New York 13210 —
Wake Forest University School of Medicine Winston-Salem North Carolina 27157-1023 —
Cleveland Clinic- Taussig Cancer Center Cleveland Ohio 44195 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —
South Carolina Oncology Group West Columbia South Carolina 29169 —
The Family Centre, PLLC Collierville Tennessee 38017 —
East Tennessee Oncology/Hematology Associates Knoxville Tennessee 37920 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00057564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2015 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00057564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →